FDA approves generic version of HIV-prevention drug to be sold in low-income countries

The U.S. FDA has approved a generic version of the world’s only twice-a-year shot to prevent HIV.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.